Foundation Fighting Blindness Retinal Degeneration Fund Ocuphire Pharma, Inc. (OCUP) insider trading activity
Foundation Fighting Blindness Retinal Degeneration Fund is Director of Ocuphire Pharma, Inc.. Currently has a direct ownership of 9.49 Million shares of OCUP, which is worth approximately $9.3 Million. The most recent transaction as insider was on May 05, 2025, when has been sold 6,927,419 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
9.49M
n/a
3M change
n/a
12M change
Total Value Held
$9.3 Million
FFB
Foundation Fighting Blindness Retinal Degeneration Fund
Director
Raleigh, NC